M67.262
Synovial hypertrophy, not elsewhere classified, left lower leg
Clinical Classification Guidelines
Medical Intelligence & Overview
Synovial hypertrophy refers to the abnormal thickening of the synovial membrane, which lines the joints and lubricates them with synovial fluid. When this condition occurs in the left lower leg, specifically outside other classified locations, it can lead to joint pain, swelling, and limited movement. The ICD-10 code M67.262 is used to classify this specific condition for medical records and insurance purposes. Recognizing the signs and understanding the potential causes can aid in managing symptoms effectively.
Causes & Symptoms
Clinical Causes: Chronic joint inflammation due to underlying conditions such as osteoarthritis or rheumatoid arthritis Repetitive joint trauma or overuse injuries Infections affecting the synovial membrane Degenerative changes linked to aging or joint wear and tear Autoimmune disorders that target joint tissues Previous joint injuries or surgeries that trigger abnormal healing responses
Key Symptoms: Persistent swelling in the affected area Joint stiffness and reduced range of motion Pain or tenderness in the left lower leg around the joint A sensation of warmth over the swollen joint Occasional redness and increased local temperature Possible joint locking or a sensation of catching
Diagnostic & Treatment
Diagnosis Path: Diagnosis of synovial hypertrophy involves clinical evaluation and imaging studies. A healthcare provider may perform a physical exam to assess swelling, tenderness, and range of motion. Imaging techniques such as ultrasound or MRI are commonly used to visualize the thickened synovial membrane and evaluate the extent of hypertrophy. In some cases, a sample of synovial fluid may be extracted for laboratory analysis to rule out infections or other conditions. Accurate diagnosis helps distinguish synovial hypertrophy from other joint abnormalities and guides effective treatment planning.
Treatment Protocols: Non-steroidal anti-inflammatory drugs (NSAIDs) to alleviate pain and reduce inflammation Physical therapy exercises to maintain joint flexibility and strength Rest and activity modification to prevent exacerbation Corticosteroid injections directly into the joint for short-term relief Surgical intervention in severe cases, such as synovectomy, to remove hypertrophied tissue Addressing underlying causes, like autoimmune diseases or degenerative conditions, with appropriate medical therapies
Clinical Advice & FAQs
Billing Guidance
Is M67.262 a billable ICD-10 code?
Yes, M67.262 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M67.262?
Clinical documentation must specify the nature of Synovial hypertrophy, not elsewhere classified, left lower leg and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
